Diabetic Under 70 (Diabetics Below 70)

AstraZeneca

Status: Completed

Conditions: Diabetes; Hyperlipidemia; Atherosclerosis

Study type: Observational

Funder types: Industry

Identifiers

NCT00516204

NIS-CAT-DUM-2007/3

NIS-CAT-CRE-2007/3

Details and patient eligibility

About

A screening project of diabetics with a very high cardiovascular risk (e.g. diabetes plus coronary heart disease) who already receive cholesterol-lowering therapy. Lipid profile and rate of patients who are treated to target (which is <70mg/dl for such patients with very high risk) are screened. The doctors therapy decisions after the screening will be documented and 8-10 weeks later the lipid profile of each patient will be evaluated again. Our aim is to evaluate dosing habits, to evaluate how many patients are treated to their LDL-C target and to underline the importance of treating patients to their cholesterol targets.

Enrollment: 685 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diabetics with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, PAVK, etc.) who already receive cholesterol-lowering therapy

Exclusion criteria

• Diabetics w/o CVD; diabetics who do not receive cholesterol-lowering therapy

Trial design

685 participants in 4 patient groups

Patients at very high risk

Patients at high risk

Patients at medium risk

Patients at low risk